HFNC and NCPAP in Extremely Preterm Infants

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

April 30, 2016

Conditions
Extreme Prematurity
Interventions
OTHER

HFNC

HFNC therapy will be delivered with a system that provides heated, humidified high flow of gas through a tube that maintains the temperature and humidification. This intervention will involve the delivery of gas (air/oxygen) at a high flow rate, using an adequate nasal cannulae size and a cannula/nostril diameter ratio between 0.5-0.8.

OTHER

NCPAP

NCPAP will be provided as either bubble CPAP or through a ventilator, and will deliver a regulated pressure of gas (air/oxygen) to the patient through infant binasal prongs as interface. Nasal prong sizes will be chosen according to manufacturer recommendations.

Trial Locations (2)

Unknown

Montreal Children's Hospital, Montreal

Royal Victoria Hospital, Montreal

All Listed Sponsors
lead

Guilherme Sant'Anna, MD

OTHER

NCT03649282 - HFNC and NCPAP in Extremely Preterm Infants | Biotech Hunter | Biotech Hunter